Can Comprehensive Genomic Profiling Be Done in 24 Hours?
Research demonstrates an automated next-generation sequencing workflow designed to reduce hands-on time while delivering next-day CGP results.
Research demonstrates an automated next-generation sequencing workflow designed to reduce hands-on time while delivering next-day CGP results.
Study shows Foresight CLARITY demonstrated 68% pre-operative and 38% post-operative MRD detection rates in stage I lung cancer patients.
The test is approved to identify patients eligible for Hernexeos, an orally administered targeted treatment for HER2 (ERBB2)-mutant non-small cell lung cancer.
mNGS significantly improves pathogen detection in pulmonary infections, enabling more precision compared to conventional methods.
Read MoreNeoGenomics and Ultima Genomics have partnered to use the UG 100 sequencing platform to advance precision oncology diagnostics.
Read MoreBruker announced major advancements at ESCMID Global, including expanded PCR assay options for its BeGenius system.
Read MoreThermo Fisher Scientific has launched the One Lambda HybriType HLA Plus Typing Flex kit, an NGS hybrid capture assay.
Read MoreChildren’s Hospital Colorado’s new in-house whole-genome sequencing lab is revolutionizing patient care by making genetic testing faster.
Read MoreUltima Genomics has launched UG 100 Solaris, an upgraded sequencing solution that enhances throughput and reduces costs.
Read MoreResearchers have developed a revolutionary method using DNA sequencing to rapidly and precisely measure metabolites critical for health.
Read MoreBaylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read MoreDatar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read MoreResearchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read MoreOGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read MoreWhile serving the region, Doylestown Health has a small clinical laboratory. To better serve its community, it added NGS in 2023.Â
Read MoreTwo studies demonstrate the potential of a genomic screening platform to improve early detection of genetic diseases in newborns.
Read MoreDelve Bio’s Delve Detect is a metagenomic sequencing test capable of quickly identifying over 68,000 pathogens from CSF.
Read MoreA mNGS test offers a rapid, comprehensive solution to diagnose a broad range of pathogens in neurological and respiratory infections.
Read More